Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
Lisa Agnello, Annachiara d’Argenio, Roberto Nilo, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2010-2010
Open Access | Times Cited: 14

Showing 14 citing articles:

Nucleic acid-based drugs for patients with solid tumours
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 14
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
Simona Camorani, Alessandra Caliendo, Elena Morrone, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Recent Advancements of Aptamers in Cancer Therapy
Swathi Venkatesan, Kaushik Chanda, M. M. Balamurali
ACS Omega (2023) Vol. 8, Iss. 36, pp. 32231-32243
Open Access | Times Cited: 18
Aptamer-based Theranostics in Oncology: Design Strategies and Limitations
J K Trivedi, Mohammad Yasir, Rahul Kumar Maurya, et al.
BIO Integration (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
A Novel Cd44-Targeting Aptamer Recognizes Chemoresistant Mesenchymal Stem-Like Tnbc Cells and Inhibits Tumor Growth
Alessandra Caliendo, Simona Camorani, Luis Exequiel Ibarra, et al.
(2025)
Closed Access
Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease
Chiara Venegoni, Silvia Tortorella, Alessandra Caliendo, et al.
Advanced Healthcare Materials (2025)
Open Access
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth
Alessandra Caliendo, Simona Camorani, Luis Exequiel Ibarra, et al.
Bioactive Materials (2025) Vol. 50, pp. 443-460
Closed Access
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
Lisa Agnello, Annachiara d’Argenio, Alessandra Caliendo, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1809-1809
Open Access | Times Cited: 8
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
Simona Camorani, Alessandra Caliendo, Elena Morrone, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer
Federico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102831-102831
Open Access | Times Cited: 1
Aptamers based targeted drug delivery system: A newer trend in cancer treatment therapy
Paramita Dey, Anushmita Ghosh, Subhrajit Sarker
Journal of Pharmaceutical and Biological Sciences (2024) Vol. 11, Iss. 2, pp. 97-104
Open Access
Integrated analysis reveals prognostic correlation and immune characteristics of a tumor-associated macrophage-based risk signature in triple-negative breast cancer
Shichen Miao, Chengyu Bian, Jun Fang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5214-5232
Open Access
Precision nanoparticles for drug delivery, cell therapy tracking, and theranostics
Delphine Felder‐Flesch, Laura Talamini, Sylviane Muller
Comptes Rendus Chimie (2024) Vol. 27, Iss. G1, pp. 241-254
Open Access
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
Desh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Prognostic correlation and immune characteristics of a TAM cluster- related 8-gene risk signature in triple-negative breast cancer
Shichen Miao, Chengyu Bian, Shanshan Wang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top